MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Impacts of White Matter Hyperintensities on Limit of Stability in Drug-naïve, de novo Patients with Idiopathic Parkinson’s Disease

    J.-H. Park, S.-K. Lee, T.-K. Lee (Bucheon-si, Republic of Korea)

    Objective: The aims of this study were to investigate the effects of incidental white matter hyperintensities(WMH) on self-initiated postural control in drug-naïve, newly diagnosed Parkinson disease…
  • 2017 International Congress

    Increased hippocampal activation in Parkinson’s disease related amnestic mild cognitive impairment

    K. Perepezko, A. Gold, A. Bakker, G. Pontone, C. Speck, L. Rosenthal (Baltimore, MD, USA)

    Objective: To assess the functional significance of hippocampal network dysfunction in Parkinson’s disease related amnestic mild cognitive impairment (PD aMCI) using high-resolution functional neuroimaging. Background:…
  • 2017 International Congress

    Hereditary spastic paraplegia type 31: a novel splice site donor mutation and intra-familial phenotypic variability

    M. Kamada, T. Kawarai, R. Miyamoto, Y. Tojima, A. Orlacchio, R. Kaji (Kita-gun, Japan)

    Objective: The aim of this study is to reveal molecular pathogenicity and genotype-phenotype correlations in Spastic Paraplegia type 31 (SPG31). Background: Mutations in REEP1 have…
  • 2017 International Congress

    Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh

    R. Hoque (Dhaka, Bangladesh)

    Objective: To determine impact of Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh. Background: Patients with Parkinson’s disease are always at risk…
  • 2017 International Congress

    The Roles of Diet, Exercise, & Supplements in Parkinson’s Disease Progression

    L. Mischley, R. Lau (Kenmore, WA, USA)

    Objective: The goal of this ongoing study is to describe whether modifiable aspects of lifestyle are associated with PD symptom severity and progression. Background: Epidemiological…
  • 2017 International Congress

    Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study interrelation of chronic pain syndrome and cognitive and affective disorders in patients with PD Background: Parkinson's disease (PD) is characterized by well-known…
  • 2017 International Congress

    Impulse Control Disorders in Early Onset and Familial PD

    R. Rees, N. Williams, Y. Ben-Shlomo, D. Grosset, H. Morris (London, United Kingdom)

    Objective: To characterize impulse control problems in early onset and familial PD (EOPD and FPD). Background: Impulse control disorders are a set of pathological behaviours…
  • 2017 International Congress

    Weight loss in Parkinson’s disease (PD)

    K. Khalid, D. Linsky, H. Khan, S. Pradhan, A. Chatterjee (Reading, United Kingdom)

    Objective: To quantify and assess weight loss in older patients with PD attending a Movement disorders clinic Background: Patients with Parkinson’s disease often lose weight…
  • 2017 International Congress

    Diagnosis of Irritable Bowel Syndrome Increases Risk of Parkinson’s Disease in the Finnish Population

    T. Mertsalmi, E. Pekkonen, F. Scheperjans (HUS, Finland)

    Objective: To assess risk of Parkinson’s disease in patients with irritable bowel syndrome in the Finnish population. Background: The majority of Parkinson’s disease (PD) patients…
  • 2017 International Congress

    AAV-mediated human alpha synuclein overexpression in the locus coeruleus (LC) leads to a neuronal loss in the nucleus ambiguus of mouse.

    B. Lee, M. Henrich, W.-H. Chiu, L. Matschke (Marburg, Germany)

    Objective: To investigate the impact and temporal aspects of the neuronal loss in the LC neurons induced by alpha-synucleinopathy Background: In the Braak staging model…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley